GMO International Developed Equity Allocation Fund
GIOTX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 40 Rowes Wharf Boston MA United States of America 02110
- IPO Date
- Jun 5, 2006
- CIK
- 0000772129
- Website
- gmo.com
- Similar Companies
- Business
- GMO International Developed Equity Allocation Fund (GIOTX) is an open-end mutual fund managed by Grantham, Mayo, Van Otterloo & Co. LLC (GMO), a Boston-based global investment management firm founded in 1977 and headquartered at 53 State Street, Suite 3300, Boston, Massachusetts. The fund operates as a fund of funds, investing primarily in equities traded in non-U.S. developed markets (including up to 10% in emerging markets at the time of purchase) through underlying GMO series such as GMO International Equity Fund, GMO International Opportunistic Value Fund, GMO-Usonian Japan Value Creation Fund, and GMO Emerging Markets Fund; it also allocates a small portion to cash equivalents like State Street Institutional Treasury Money Market Investment. GMO combines top-down asset allocation views with bottom-up equity research to identify mispricings across asset classes and individual securities, targeting total return greater than the MSCI EAFE Index, with a focus on large-cap value stocks in the foreign large value category. The fund, launched on June 5, 2006, maintains total net assets of approximately $190 million, a net expense ratio of 0.64%, and low portfolio turnover of 11%, serving institutional and retail investors seeking exposure to international developed equities. It is domiciled in the United States and priced daily in USD, with primary managers including Ben Inker (since inception) and John Thorndike (since June 30, 2019). GMO, which oversees the fund, manages a diverse range of equity, fixed income, and multi-asset strategies globally, with affiliate offices in Amsterdam, London, San Francisco, Singapore, Sydney, and Tokyo. Recent portfolio data as of late 2025 reflects allocations dominated by top holdings exceeding 100% of the portfolio in GMO International Equity Fund Class IV (69.77%), GMO International Opportunistic Value Fund Class IV (23.15%), and GMO-Usonian Japan Value Creation Fund Class VI (7.02%), alongside minimal cash positions, indicating ongoing strategic emphasis on active international equity selection amid market conditions. No major acquisitions, partnerships, funding rounds, or structural reorganizations specific to the fund have been reported in the last 1-2 years, though GMO continues to evolve its underlying strategies in response to global valuation shifts and asset allocation outlooks. The fund has delivered year-to-date returns of approximately 22-32% through late 2025, outperforming its benchmark in recent periods while maintaining its value-oriented mandate.